Markus Warmuth, President & CEO: Monte Rosa Therapeutics GLUE Planned sale · Filed 05/01

Trade details

Type: Planned sale notice
Stock: Monte Rosa Therapeutics GLUE
Person: Markus WarmuthPresident & CEO
Planned sale date: 26/05/01
Filed: 26/05/01

More to sell after $239.1K in 3 months

Monte Rosa Therapeutics trades, last 26 weeks

What else happened in Monte Rosa Therapeutics around then

Filed or reported within 30 days of the trade day · 04/01~05/31

Markus Warmuth's recent trades

Markus WarmuthPresident & CEO
Planned saleMonte Rosa Therapeutics
Planned sale
Monte Rosa Therapeutics
GLUE
$220.2K
9,500 sh
$220.2K
Filed 07/16
Traded 07/16
Markus WarmuthPresident & CEO
Sell10b5-1 planMonte Rosa Therapeutics
Sell10b5-1 plan
Monte Rosa Therapeutics
GLUE
$97K
4,998 sh
$97K
Filed 06/02
Traded 06/01
Markus WarmuthPresident & CEO
Sell10b5-1 planMonte Rosa Therapeutics
Sell10b5-1 plan
Monte Rosa Therapeutics
GLUE
$9,234
468 sh
$9,234
Filed 06/02
Traded 06/01
Markus WarmuthPresident & CEO
Planned sale10b5-1 planMonte Rosa Therapeutics
Planned sale10b5-1 plan
Monte Rosa Therapeutics
GLUE
$106.3K
5,466 sh
$106.3K
Filed 06/01
Traded 06/01
Markus WarmuthPresident & CEO
Sell10b5-1 planMonte Rosa Therapeutics
Sell10b5-1 plan
Monte Rosa Therapeutics
GLUE
$103.4K
5,467 sh
$103.4K
Filed 05/05
Traded 05/01

Markus Warmuth, CEO — plans to sell 5,467 sh of Monte Rosa Therapeutics GLUE · $103.4M · around 05/01 · 10b5-1 plan | Whalegun